Cargando…

Risk of all-cause mortality according to the European Society of Cardiology risk categories in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study

AIMS: The 2019 and 2021 European Society of Cardiology (ESC) classifications stratified patients with type 2 diabetes into three categories according to the 10-year risk of death from atherosclerotic cardiovascular disease (ASCVD). The very high-risk category included individuals with established AS...

Descripción completa

Detalles Bibliográficos
Autores principales: Orsi, Emanuela, Solini, Anna, Bonora, Enzo, Vitale, Martina, Garofolo, Monia, Fondelli, Cecilia, Trevisan, Roberto, Vedovato, Monica, Cavalot, Franco, Laviola, Luigi, Morano, Susanna, Pugliese, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402482/
https://www.ncbi.nlm.nih.gov/pubmed/35902419
http://dx.doi.org/10.1007/s00592-022-01942-8
_version_ 1784773187475603456
author Orsi, Emanuela
Solini, Anna
Bonora, Enzo
Vitale, Martina
Garofolo, Monia
Fondelli, Cecilia
Trevisan, Roberto
Vedovato, Monica
Cavalot, Franco
Laviola, Luigi
Morano, Susanna
Pugliese, Giuseppe
author_facet Orsi, Emanuela
Solini, Anna
Bonora, Enzo
Vitale, Martina
Garofolo, Monia
Fondelli, Cecilia
Trevisan, Roberto
Vedovato, Monica
Cavalot, Franco
Laviola, Luigi
Morano, Susanna
Pugliese, Giuseppe
author_sort Orsi, Emanuela
collection PubMed
description AIMS: The 2019 and 2021 European Society of Cardiology (ESC) classifications stratified patients with type 2 diabetes into three categories according to the 10-year risk of death from atherosclerotic cardiovascular disease (ASCVD). The very high-risk category included individuals with established ASCVD, target organ damage (TOD), and/or, in the 2019 classification only, ≥ 3 additional ASCVD risk factors. We assessed risk of all-cause mortality according to the two ESC classifications in the Renal Insufficiency And Cardiovascular Events cohort. METHODS: Participants (n = 15,773) were stratified based on the presence of ASCVD, TOD, and ASCVD risk factors at baseline (2006–2008). Vital status was retrieved in 2015. RESULTS: Less than 1% of participants fell in the moderate-risk category. According to the 2019 classification, ~ 1/3 fell in the high-risk and ~ 2/3 in the very high-risk category, whereas the opposite occurred with the 2021 classification. Mortality risk increased across categories according to both classifications. Among very high-risk patients, mortality was much lower in those with ≥ 3 additional ASCVD risk factors and almost equal in those with TOD and ASCVD ± TOD, using the 2019 classification, whereas it was much higher in those with ASCVD + TOD and, to a lesser extent, TOD only than in those with ASCVD only, using the 2021 classification. CONCLUSIONS: The negligible number of moderate-risk patients suggests that these classifications might overestimate risk of ASCVD death. Downgrading patients with ≥ 3 additional ASCVD risk factors to the high-risk category is consistent with mortality data. Risk of death is very high in the presence of TOD irrespective of established ASCVD. Trial registration: ClinicalTrials.gov, NCT00715481. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00592-022-01942-8.
format Online
Article
Text
id pubmed-9402482
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-94024822022-08-26 Risk of all-cause mortality according to the European Society of Cardiology risk categories in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study Orsi, Emanuela Solini, Anna Bonora, Enzo Vitale, Martina Garofolo, Monia Fondelli, Cecilia Trevisan, Roberto Vedovato, Monica Cavalot, Franco Laviola, Luigi Morano, Susanna Pugliese, Giuseppe Acta Diabetol Original Article AIMS: The 2019 and 2021 European Society of Cardiology (ESC) classifications stratified patients with type 2 diabetes into three categories according to the 10-year risk of death from atherosclerotic cardiovascular disease (ASCVD). The very high-risk category included individuals with established ASCVD, target organ damage (TOD), and/or, in the 2019 classification only, ≥ 3 additional ASCVD risk factors. We assessed risk of all-cause mortality according to the two ESC classifications in the Renal Insufficiency And Cardiovascular Events cohort. METHODS: Participants (n = 15,773) were stratified based on the presence of ASCVD, TOD, and ASCVD risk factors at baseline (2006–2008). Vital status was retrieved in 2015. RESULTS: Less than 1% of participants fell in the moderate-risk category. According to the 2019 classification, ~ 1/3 fell in the high-risk and ~ 2/3 in the very high-risk category, whereas the opposite occurred with the 2021 classification. Mortality risk increased across categories according to both classifications. Among very high-risk patients, mortality was much lower in those with ≥ 3 additional ASCVD risk factors and almost equal in those with TOD and ASCVD ± TOD, using the 2019 classification, whereas it was much higher in those with ASCVD + TOD and, to a lesser extent, TOD only than in those with ASCVD only, using the 2021 classification. CONCLUSIONS: The negligible number of moderate-risk patients suggests that these classifications might overestimate risk of ASCVD death. Downgrading patients with ≥ 3 additional ASCVD risk factors to the high-risk category is consistent with mortality data. Risk of death is very high in the presence of TOD irrespective of established ASCVD. Trial registration: ClinicalTrials.gov, NCT00715481. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00592-022-01942-8. Springer Milan 2022-07-28 2022 /pmc/articles/PMC9402482/ /pubmed/35902419 http://dx.doi.org/10.1007/s00592-022-01942-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Orsi, Emanuela
Solini, Anna
Bonora, Enzo
Vitale, Martina
Garofolo, Monia
Fondelli, Cecilia
Trevisan, Roberto
Vedovato, Monica
Cavalot, Franco
Laviola, Luigi
Morano, Susanna
Pugliese, Giuseppe
Risk of all-cause mortality according to the European Society of Cardiology risk categories in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study
title Risk of all-cause mortality according to the European Society of Cardiology risk categories in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study
title_full Risk of all-cause mortality according to the European Society of Cardiology risk categories in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study
title_fullStr Risk of all-cause mortality according to the European Society of Cardiology risk categories in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study
title_full_unstemmed Risk of all-cause mortality according to the European Society of Cardiology risk categories in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study
title_short Risk of all-cause mortality according to the European Society of Cardiology risk categories in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study
title_sort risk of all-cause mortality according to the european society of cardiology risk categories in individuals with type 2 diabetes: the renal insufficiency and cardiovascular events (riace) italian multicenter study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402482/
https://www.ncbi.nlm.nih.gov/pubmed/35902419
http://dx.doi.org/10.1007/s00592-022-01942-8
work_keys_str_mv AT orsiemanuela riskofallcausemortalityaccordingtotheeuropeansocietyofcardiologyriskcategoriesinindividualswithtype2diabetestherenalinsufficiencyandcardiovasculareventsriaceitalianmulticenterstudy
AT solinianna riskofallcausemortalityaccordingtotheeuropeansocietyofcardiologyriskcategoriesinindividualswithtype2diabetestherenalinsufficiencyandcardiovasculareventsriaceitalianmulticenterstudy
AT bonoraenzo riskofallcausemortalityaccordingtotheeuropeansocietyofcardiologyriskcategoriesinindividualswithtype2diabetestherenalinsufficiencyandcardiovasculareventsriaceitalianmulticenterstudy
AT vitalemartina riskofallcausemortalityaccordingtotheeuropeansocietyofcardiologyriskcategoriesinindividualswithtype2diabetestherenalinsufficiencyandcardiovasculareventsriaceitalianmulticenterstudy
AT garofolomonia riskofallcausemortalityaccordingtotheeuropeansocietyofcardiologyriskcategoriesinindividualswithtype2diabetestherenalinsufficiencyandcardiovasculareventsriaceitalianmulticenterstudy
AT fondellicecilia riskofallcausemortalityaccordingtotheeuropeansocietyofcardiologyriskcategoriesinindividualswithtype2diabetestherenalinsufficiencyandcardiovasculareventsriaceitalianmulticenterstudy
AT trevisanroberto riskofallcausemortalityaccordingtotheeuropeansocietyofcardiologyriskcategoriesinindividualswithtype2diabetestherenalinsufficiencyandcardiovasculareventsriaceitalianmulticenterstudy
AT vedovatomonica riskofallcausemortalityaccordingtotheeuropeansocietyofcardiologyriskcategoriesinindividualswithtype2diabetestherenalinsufficiencyandcardiovasculareventsriaceitalianmulticenterstudy
AT cavalotfranco riskofallcausemortalityaccordingtotheeuropeansocietyofcardiologyriskcategoriesinindividualswithtype2diabetestherenalinsufficiencyandcardiovasculareventsriaceitalianmulticenterstudy
AT laviolaluigi riskofallcausemortalityaccordingtotheeuropeansocietyofcardiologyriskcategoriesinindividualswithtype2diabetestherenalinsufficiencyandcardiovasculareventsriaceitalianmulticenterstudy
AT moranosusanna riskofallcausemortalityaccordingtotheeuropeansocietyofcardiologyriskcategoriesinindividualswithtype2diabetestherenalinsufficiencyandcardiovasculareventsriaceitalianmulticenterstudy
AT pugliesegiuseppe riskofallcausemortalityaccordingtotheeuropeansocietyofcardiologyriskcategoriesinindividualswithtype2diabetestherenalinsufficiencyandcardiovasculareventsriaceitalianmulticenterstudy
AT riskofallcausemortalityaccordingtotheeuropeansocietyofcardiologyriskcategoriesinindividualswithtype2diabetestherenalinsufficiencyandcardiovasculareventsriaceitalianmulticenterstudy